SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 41 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,000 | -59.3% | 40,414 | -36.4% | 0.00% | – |
| Q1 2020 | $27,000 | +575.0% | 63,566 | +385.2% | 0.00% | – |
| Q4 2019 | $4,000 | -73.3% | 13,100 | -35.8% | 0.00% | – |
| Q3 2019 | $15,000 | -6.2% | 20,400 | -10.1% | 0.00% | – |
| Q2 2019 | $16,000 | -5.9% | 22,700 | +57.6% | 0.00% | – |
| Q1 2019 | $17,000 | -92.1% | 14,400 | -86.6% | 0.00% | – |
| Q3 2018 | $216,000 | +68.8% | 107,697 | +130.2% | 0.00% | – |
| Q2 2018 | $128,000 | 0.0% | 46,778 | 0.0% | 0.00% | – |
| Q1 2018 | $128,000 | -48.2% | 46,778 | -30.4% | 0.00% | – |
| Q4 2017 | $247,000 | +648.5% | 67,186 | +290.6% | 0.00% | – |
| Q3 2017 | $33,000 | -45.9% | 17,200 | -23.2% | 0.00% | – |
| Q2 2017 | $61,000 | -63.3% | 22,400 | -44.7% | 0.00% | – |
| Q1 2017 | $166,000 | +46.9% | 40,472 | +29.7% | 0.00% | -100.0% |
| Q4 2016 | $113,000 | -46.4% | 31,200 | -35.9% | 0.00% | 0.0% |
| Q3 2016 | $211,000 | – | 48,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|